Patent Yard Sign in
Canadian application, no grantCanada

Method to treat infectious diseases and/or to enhance antimicrobial efficacy of drugs

CA 2417627 A1 · Owner: Borgeat, Pierre · Inventors: Tremblay, Michel J.; Flamand, Louis; Gosselin, Jean

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The present invention provides a method for the treatment of a viral infection in a patient by administration of a bis-peroxovanadium (bpV) compound a , potent class of phosphotyrosyl phosphatase inhibitors. The method can be utilized for the treatment of patients suffering from infections caused by viruses, such as the human immunodeficiency virus (HIV). The bpV compound may be used in combination with various immunomodulators and/or antiviral agents in particular, 3TC of which it promotes the phosphorylation into the triphosphate form.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed July 23, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended July 23, 2021.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 23, 2023.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJuly 23, 2001
GrantedNo grant recorded
Term endedJuly 23, 2021
Patent numberCA 2417627 A1
Classification (IPC)A61K31/00 +2 more

Timeline

Timeline From CIPO dates

2002200420062008201020122014201620182020Application filedJuly 23, 2001Term endedJuly 23, 2021

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.